# Experimental Bone Marrow Transplant Protocol

> **NCT00061581** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 14 (actual)

## Conditions studied

- Acute Lymphocytic Leukemia
- Chronic Myeloid Leukemia
- Acute Myelocytic Leukemia
- Myelodysplastic Syndromes
- Myeloproliferative Disorders

## Interventions

- **DEVICE:** Isolex 300i Stem Cell Selection

## Key facts

- **NCT ID:** NCT00061581
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05-19
- **Primary completion:** 2007-12-28
- **Final completion:** 2017-06-14
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00061581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00061581, "Experimental Bone Marrow Transplant Protocol". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00061581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*